Shows
AI UncoveredEmmanuel Walckenaer: AI’s Real-World Impact on Pharma & What’s Next in 2025We’re thrilled to welcome Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in transforming content generation.In this episode, Tim and Emmanuel revisit the biggest AI breakthroughs of 2024 and explore how the pharmaceutical sector is shifting from skepticism to large-scale adoption. They discuss real-world success stories, the growing impact of feder...2025-02-2023 min
AI UncoveredFred Schonenberg - The Vital Role of GenAI in EnterprisesWe welcome Fred Schonenberg to AI Uncovered. Fred is the founder and CEO of VentureFuel. He has created an innovation framework that bridges the VC, Angel, and Startup ecosystem with enterprises to deliver tangible technology solutions that drive growth. In his role at Venture Fuel, Fred has worked with over 100 companies from General Mills to Netflix.He is a frequent speaker at industry events such as SXSW, Ad Tech, and Advertising Week and is published in broad media publications including Huffington post, Creator Magazine and Ad Week. In this episode Tim and Fred discuss generative...2024-03-0437 min
AI UncoveredEmmanuel Walckenaer - "In the next five years, 80% of the life sciences industry will be using this type of AI"The second episode features a conversation with Emmanuel Walckenaer, CEO of Yseop. Yseop is reimagining the future of scientific writing through generative AI. The company's mission is to get medicine into the hands of those who need it, faster.Tim and Emmanuel shares insights on the state of natural language generation (NLG) today and the roots of the technology. They discuss how generative AI is automating parts of the clinical document landscape and why the tech is helping scientific writers be more productive. Welcome to AI Uncovered2023-04-0329 min
AI UncoveredCraig Vachon - “I still think ChatGPT is kind of a gimmick”The first episode features a conversation with Craig Vachon, CEO of AI Redefined (AIR) and Head of US Operations at NextStage AM. Craig is an angel investor, author, TED speaker, and chairman of Yseop. Tim and Craig discuss the AI landscape as it exists today and then go into the benefits and limitations of ChatGPT and LLMs, especially for more regulated industries. They touch on some of the challenges involved with AI startups, advice for entrepreneurs, and practical considerations of rolling out AI technology to customers. Welcome to ...2023-03-0126 min
The Bio ReportHow AI Is Finding Its Way into Unexpected Places in Biopharma CompaniesWhen people think of the potential for artificial intelligence to impact the biopharmaceutical industry, the focus is usually on drug discovery or in the clinic to help guide decision making with regards to pairing the right drug to the right patient. Yseop is focused on a more mundane use for the technology—the writing of clinical data reports. The company had been working in the financial services industry when it was approached by Sanofi to see if it could apply its natural language generation to make the creation of these reports faster and less expensive. We spoke to Emmanuel Walckenaer, CE...2023-01-1234 min
Passionate Pioneers with Mike BiselliHelping Bring Therapeutics to Market Faster with Emmanuel WalckenaerEpisode Sponsor:---This episode’s Community Champion Sponsor is Salesforce. Salesforce believes the future of health is connected, do you? Learn more at www.salesforce.com/businessofhealthHear from Kevin Riley, Salesforce’s Chief Customer Officer, on this podcast: CLICK HERE---Episode Overview: In today’s life sciences environment, developing and approving new drugs can take upwards of twelve to 15 years. One significant reason for these arduous processes and timelines is the lack of automation and artificial intelligence integration. Our next guest and his company are poi...2022-09-2632 min
The AI in Business PodcastAugmentation, Not Replacement: Debunking Common AI Myths Life Sciences - with Emmanuel Walckenaer of YSEOPToday’s guest is Emmanuel Walckenaer, CEO of YSEOP. In this episode, we discuss two core questions: first, how are enterprise leaders measuring the success of AI programs that are being used to augment human productivity? The second question is about where humans fit in the loop. In other words, why are humans still critical for certain kinds of workflows and decision-making processes? Emmanuel discusses the concepts of accountability and transparency and how those themes fit into humans’ role as orchestrators of AI in the enterprise. He also gives his perspective on where he sees augmentation happen in the life...2022-05-3130 min
The AI in Business PodcastImproving Drug Development Speed with AI in Life Sciences - with Emmanuel Walckenaer of YSEOPToday’s guest is Emmanuel Walckenaer, CEO of YSEOP. YSEOP is a natural language generation AI vendor serving life sciences and drug development. In today’s episode, Emmanuel speaks about speeding up the drug development process through the lens of the life sciences industry being in extreme flux and what happens when a new normal is achieved and how companies have to scramble to keep up with it. Emmanuel also talks about the expansion of AI projects and capabilities in the enterprise. Today’s episode is brought to you by YSEOP. If you’re an AI vendor looking to reach a...2022-03-0834 min
The AI in Business PodcastAutomating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOPToday’s guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he’s seen in his work in the life sciences space. This episode is sponsored by YSEOP. If you’re interested in reaching the Emerj audience, you have an important educational messag...2021-07-2728 min
The AI in Business PodcastStreamlining Financial Reporting with AI and NLG - with Emmanuel Walckenaer of YSEOPToday's guest is Emmanual Walckenaer, CEO of YSEOP, a company based in Paris and focused on Natural Language Generation. Emmanuel speaks to us today about workflows where automating reporting really delivers value, and we talk about two, in particular, one of which is credit risk. Understanding and assessing it, and what does that process look like today? What kind of data and insights are required, and where does AI fit into the mix? And we also look at improving report quality for people that are controllers or analysts. Emmanuel explores how the use cases work and how the underpinning...2021-05-2531 min
UPPY! (AUDIO)UPPY! S02E01 : Sowefund, Koolicar, Yseop et les news d'Ilan AbehasseraC'est le retour d'Uppy!, le magazine des startups et de la nouvelle économie présenté par Bertrand Lenotre et Jennyfer Aizenman en collaboration avec Digital Business News. Au sommaire de ce 21eme épisode, la chronique américiane d'Ilan Abehassera depuis New York où il est retourné s'installer après un passage dans la Silicon Valley. L'aventure Porducteev, revendu à Jive, est derrière lui. Ilan se consacre désormais à un nouveau projet très secret : Insensi Inc. Aujourd'hui, il évoque :
Lobjet connecté de la semaine : Electric Object
L'arrivée de Deezer aux USA dans une approche très haut de gamme
2 belles le...2014-09-1957 min
UPPY! (HD)UPPY! S02E01 : Sowefund, Koolicar, Yseop et les news d'Ilan AbehasseraC'est le retour d'Uppy!, le magazine des startups et de la nouvelle économie présenté par Bertrand Lenotre et Jennyfer Aizenman en collaboration avec Digital Business News. Au sommaire de ce 21eme épisode, la chronique américiane d'Ilan Abehassera depuis New York où il est retourné s'installer après un passage dans la Silicon Valley. L'aventure Porducteev, revendu à Jive, est derrière lui. Ilan se consacre désormais à un nouveau projet très secret : Insensi Inc. Aujourd'hui, il évoque :
Lobjet connecté de la semaine : Electric Object
L'arrivée de Deezer aux USA dans une approche très haut de gamme
2 belles lev...2014-09-1957 min
UPPY! (MEDIUM)UPPY! S02E01 : Sowefund, Koolicar, Yseop et les news d'Ilan AbehasseraC'est le retour d'Uppy!, le magazine des startups et de la nouvelle économie présenté par Bertrand Lenotre et Jennyfer Aizenman en collaboration avec Digital Business News. Au sommaire de ce 21eme épisode, la chronique américiane d'Ilan Abehassera depuis New York où il est retourné s'installer après un passage dans la Silicon Valley. L'aventure Porducteev, revendu à Jive, est derrière lui. Ilan se consacre désormais à un nouveau projet très secret : Insensi Inc. Aujourd'hui, il évoque :
Lobjet connecté de la semaine : Electric Object
L'arrivée de Deezer aux USA dans une approche très haut de gamme
2 belles lev...2014-09-1957 min
UPPY! (SMALL)UPPY! S02E01 : Sowefund, Koolicar, Yseop et les news d'Ilan AbehasseraC'est le retour d'Uppy!, le magazine des startups et de la nouvelle économie présenté par Bertrand Lenotre et Jennyfer Aizenman en collaboration avec Digital Business News. Au sommaire de ce 21eme épisode, la chronique américiane d'Ilan Abehassera depuis New York où il est retourné s'installer après un passage dans la Silicon Valley. L'aventure Porducteev, revendu à Jive, est derrière lui. Ilan se consacre désormais à un nouveau projet très secret : Insensi Inc. Aujourd'hui, il évoque :
Lobjet connecté de la semaine : Electric Object
L'arrivée de Deezer aux USA dans une approche très haut de gamme
2 belles lev...2014-09-1957 min